United States: "A Lucrative Micro-Niche: Synthetic Biology"

Last Updated: September 25 2019
Article by Jennifer Burnette

What is synthetic biology? At a fundamental level, synthetic biology is an interdisciplinary area applying engineering principles to biology to better design and fabricate complex, biological components and systems having functions that do not exist in nature. The technology is quickly evolving, greatly expanding the utility of biotechnology for a variety of industries.

For law firms this field offers opportunities to help clients in legal questions over intellectual property; regulatory compliance; risk assessment; environmental concerns; and biosafety and biosecurity among other areas. For many law firm clients, such legal challenges related to biotechnology will be unfamiliar, and strategies relied upon by traditional biotechnology companies may not be a good fit for such clients.

Take intellectual property, for example. The pharmaceutical industry has traditionally widely invested in biotechnology for development of new drugs, such as biologics. In doing so, pharmaceutical companies invest heavily on building robust intellectual property portfolios, particularly large patent portfolios, for long-term protection of what is hoped to be a blockbuster drug. The length of time and financial investment required to bring a drug to market, combined with the significant anticipated revenue to be drawn from exclusivity of a blockbuster drug motivates such companies to invest both time and money to build robust patent portfolios.

Synthetic biology, however, has applicability in industries with significantly faster product turnover and even commodities-type products. Lega strategies for protection of synthetic biology innovations will need to be adapted to the market in which such products will be used.

Turn to Synthetic Biology for Innovation

Synthetic biology represents what I have come to label a tech-driven hybrid capable of being a technology disruptor to many conventional industries and particularly industries that are not even typically utilizing biotechnology.

If you are serving clients in a particular industry, you do not want to be the attorney who is asked “What do you know about synthetic biology?” and not have some kind of reasonable answer.

Here are some brief examples where the application of engineering principles to biology (via manipulation of DNA and other methods) are already having an impact:

  • Industrial Chemicals — engineering bacteria to produce paints, adhesives, and cleaners;
  • BioFuels — creating new renewable energy sources from microbes;
  • Software — using more efficiently designed DNA sequencing (g. CRISPR editing);
  • AgriBusiness — developing enzymes to improve crop yields and pest resistance;
  • Consumer Products — manufacturing bacteria capable of producing collagen, which is then bundled to produce a leather hide;
  • Food & Drink — producing synthetic wine without grapes; and
  • Healthcare — discovering new pharmaceuticals and treatment diagnostics.

For example, in healthcare today, genetic engineers want to make bio-pot — a syntheticly engineered strain of marijuana — for fun and health. Synthetic-biology company Amyris believes it can genetically engineer organisms to manufacture cannabinoids, the active molecules in marijuana, more cheaply than by growing plants. If it works, cannabinoids could end up everywhere, in new forms, and reaching new people. Despite some moral qualms, the biotech industry is increasingly embracing the legal cannabis sector, which is growing rapidly on the back of spreading legalization in the U.S. and beyond.

Meanwhile, we can also view synthetic biology as its own emerging industry wherein innovative entrepreneurs are exploring how new cell-produced products might replace traditional industrial and chemical processes. Here are but a few examples of the kinds of companies you could be working with if you were developing a practice in this particular micro-niche:

  • Ambercycle is working on cell-based alternatives to many of our polluting petroleum products, including plastics, by trying to make plastic recycling profitable and sustainable by using synthetic biology to engineer custom-tailored organisms that can degrade plastics into its chemical components.
  • A bacteria found in the gut of a rabbit, identified by biotech start-up LanzaTech, can now help cars run in a more eco-friendly way by turning factory carbon emissions into ethanol, an alcohol that is blended with gasoline to reduce the amount of fuel used by cars.
  • Similarly, C16 BioSciences, is making a lab-grown alternative to palm oil, which it claims is 20% cheaper and isn’t as destructive as the environmentally-devastating palm oil that is a common ingredient in many consumer products.
  • Geltor is using synthetic biology techniques to engineer micro-organisms to produce animal-free collagen for the cosmetics industry. And, a German company, AMSilk introduced a liquid-silk coating (made from modified E. coli bacteria), for use in medical and cosmetic implants.
  • Zymergen researches, develops, and manufactures microbes for Fortune 500 companies in areas of agriculture, chemicals, materials, pharmaceuticals, electronics, personal care, and more.
  • Ecovative Design is a biomaterials company that provides sustainable alternatives to plastics and polystyrene foams for packaging, building materials, and other applications by using mushroom technology.
  • Calysta is chiefly involved in the development of industrial processes that utilize micro-organisms to convert methane into protein for seafood and livestock feed and other useful products like fuel and plastics.
  • Bolt Threads focuses on harnessing proteins found in nature — mostly using spider silk — to engineer renewable fibers and fabrics with both practical and revolutionary uses.

Indeed, this particular micro-niche even has its own annual international forum, SynBiTech, for experts engaged in synthetic biology research, commercialization, investment and policymaking in this area. SynBiTech 2019, held this past June in London, focused on the key opportunities and challenges for building a multibillion-dollar synthetic biology industry that will contribute to the fast-growing bio-economy.

The June event offered two days of intense presentations, even featuring a few presenters from the investment community… but not a single lawyer at the podium — a true sign of this still being an “emerging” micro-niche.

Originally published on Thomson Reuters Legal Executive Institute blog: http://www.legalexecutiveinstitute.com/micro-niche-synthetic-biology/

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions